Paul J Hastings
CIK 1309702 · Lihat di SEC EDGAR ↗
Pengajuan SEC Pertama: 9 Juli 2020 · Terbaru: 9 Juli 2020
Di halaman ini
- Orang Dalam di Perusahaan di mana orang ini adalah orang dalam yang melaporkan.
- Transaksi orang dalam Setiap saham yang dibeli atau dijual orang ini, dari pengajuan Formulir 4.
- Derivatif Opsi dan kepemilikan derivatif lainnya yang dilaporkan oleh orang ini.
- Kepemilikan Awal Kepemilikan yang dimiliki orang ini saat pertama kali mulai melaporkan.
- Kompensasi Gaji eksekutif yang diungkapkan dalam pernyataan proksi perusahaan.
Orang Dalam di
Transaksi orang dalam
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 18 Juni 2026 | NKTX | S | 1.776 | $2,71 | $4.813 | 390.247 Langsung | -0,45% | Dilepas | -6,3% (harga per 2026-08-21) |
| 15 Jan. 2026 | NKTX | S | 26.046 | $2,07 | $53.915 | 390.023 Langsung | -6,26% | Dilepas | 22,6% (harga per 2026-08-21) |
| 18 Juni 2025 | NKTX | S | 1.790 | $1,79 | $3.204 | 320.069 Langsung | -0,56% | Dilepas | 41,8% (harga per 2026-08-21) |
| 15 Jan. 2025 | NKTX | S | 17.378 | $2,20 | $38.232 | 319.859 Langsung | -5,15% | Dilepas | 15,4% (harga per 2026-08-21) |
| 18 Juni 2024 | NKTX | S | 1.770 | $5,60 | $9.912 | 240.737 Langsung | -0,73% | Dilepas | -54,7% (harga per 2026-08-21) |
| 13 Juni 2024 | PCRX | S 10b5-1 | 880 | $28,38 | $24.974 | 12.724 Langsung | -6,47% | Dilepas | -15,5% (harga per 2026-08-21) |
| 16 Jan. 2024 | NKTX | S | 9.697 | $8,74 | $84.752 | 390.507 Langsung | -2,42% | Dilepas | -71,0% (harga per 2026-08-21) |
| 20 Juni 2023 | NKTX | S | 1.704 | $4,85 | $8.264 | 313.402 Langsung | -0,54% | Dilepas | -47,7% (harga per 2026-08-21) |
| 5 Juni 2023 | PCRX | S | 580 | $38,34 | $22.237 | 6.599 Langsung | -8,08% | Dilepas | -37,4% (harga per 2026-08-21) |
| 15 Mei 2023 | PCRX | S 10b5-1 | 7.000 | $41,85 | $292.950 | 7.179 Langsung | -49,37% | Dilepas | -42,7% (harga per 2026-08-21) |
| 17 Jan. 2023 | NKTX | S | 3.691 | $5,49 | $20.264 | 313.106 Langsung | -1,17% | Dilepas | -53,8% (harga per 2026-08-21) |
| 29 Sep. 2022 | NKTX | S 10b5-1 | 498 | $13,00 | $6.474 | 250.461 Langsung | -0,20% | Dilepas | -80,5% (harga per 2026-08-21) |
| 28 Sep. 2022 | NKTX | S 10b5-1 | 23.376 | $13,03 | $304.589 | 250.959 Langsung | -8,52% | Dilepas | -80,5% (harga per 2026-08-21) |
| 21 Sep. 2022 | NKTX | S 10b5-1 | 6.126 | $13,01 | $79.699 | 274.335 Langsung | -2,18% | Dilepas | -80,5% (harga per 2026-08-21) |
| 11 Juli 2022 | PCRX | S 10b5-1 | 533 | $56,95 | $30.354 | 7.179 Langsung | -6,91% | Dilepas | -57,9% (harga per 2026-08-21) |
| 29 Sep. 2021 | NKTX | S 10b5-1 | 223 | $26,53 | $5.916 | 219.061 Langsung | -0,10% | Dilepas | -90,4% (harga per 2026-08-21) |
| 29 Sep. 2021 | NKTX | S 10b5-1 | 8.277 | $27,20 | $225.134 | 219.284 Langsung | -3,64% | Dilepas | -90,7% (harga per 2026-08-21) |
| 21 Juni 2021 | NKTX | S 10b5-1 | 4.693 | $26,39 | $123.848 | 231.368 Langsung | -1,99% | Dilepas | -90,4% (harga per 2026-08-21) |
| 21 Juni 2021 | NKTX | S 10b5-1 | 3.807 | $26,89 | $102.370 | 227.561 Langsung | -1,65% | Dilepas | -90,6% (harga per 2026-08-21) |
| 4 Juni 2021 | PCRX | S 10b5-1 | 630 | $62,19 | $39.180 | 5.486 Langsung | -10,30% | Dilepas | -61,4% (harga per 2026-08-21) |
| 30 Maret 2021 | NKTX | S 10b5-1 | 3.130 | $32,21 | $100.817 | 236.061 Langsung | -1,31% | Dilepas | -92,1% (harga per 2026-08-21) |
| 30 Maret 2021 | NKTX | S 10b5-1 | 2.409 | $31,24 | $75.257 | 239.191 Langsung | -1,00% | Dilepas | -91,9% (harga per 2026-08-21) |
| 30 Maret 2021 | NKTX | S 10b5-1 | 11.461 | $30,23 | $346.466 | 241.600 Langsung | -4,53% | Dilepas | -91,6% (harga per 2026-08-21) |
| 5 Maret 2021 | PCRX | S | 3.000 | $65,88 | $197.640 | 6.116 Langsung | -32,91% | Dilepas | -63,6% (harga per 2026-08-21) |
| 4 Juni 2020 | PCRX | S | 2.025 | $47,46 | $96.106 | 4.856 Langsung | -29,43% | Dilepas | -49,5% (harga per 2026-08-21) |
| 4 Juni 2019 | PCRX | S 10b5-1 | 782 | $42,66 | $33.360 | 2.747 Langsung | -22,16% | Dilepas | -43,8% (harga per 2026-08-21) |
| 4 Juni 2018 | PCRX | S | 771 | $33,90 | $26.137 | 2.747 Langsung | -21,92% | Dilepas | -29,2% (harga per 2026-08-21) |
| 22 Agu 2017 | PCRX | S | 1.044 | $36,15 | $37.741 | 3.518 Langsung | -22,88% | Dilepas | -33,6% (harga per 2026-08-21) |
| 6 Juni 2016 | PCRX | S 10b5-1 | 1.136 | $46,95 | $53.335 | 1.717 Langsung | -39,82% | Dilepas | -48,9% (harga per 2026-08-21) |
| 17 Feb. 2016 | PCRX | S 10b5-1 | 3.000 | $60,00 | $180.000 | 2.853 Langsung | -51,26% | Dilepas | -60,0% (harga per 2026-08-21) |
| 20 Nov. 2015 | PCRX | S 10b5-1 | 3.000 | $60,00 | $180.000 | 2.853 Langsung | -51,26% | Dilepas | -60,0% (harga per 2026-08-21) |
| 17 Agu 2015 | PCRX | S 10b5-1 | 3.000 | $60,02 | $180.060 | 2.853 Langsung | -51,26% | Dilepas | -60,0% (harga per 2026-08-21) |
| 10 April 2015 | PCRX | S 10b5-1 | 2.500 | $88,00 | $220.000 | 853 Langsung | -74,56% | Dilepas | -72,7% (harga per 2026-08-21) |
| 12 Jan. 2015 | PCRX | S 10b5-1 | 2.500 | $94,06 | $235.150 | 853 Langsung | -74,56% | Dilepas | -74,5% (harga per 2026-08-21) |
| 10 Okt. 2014 | PCRX | S 10b5-1 | 2.500 | $94,87 | $237.175 | 853 Langsung | -74,56% | Dilepas | -74,7% (harga per 2026-08-21) |
| 10 Juli 2014 | PCRX | S 10b5-1 | 698 | $85,96 | $60.000 | 853 Langsung | -45,00% | Dilepas | -72,1% (harga per 2026-08-21) |
| 10 Juli 2014 | PCRX | S 10b5-1 | 502 | $85,03 | $42.685 | 1.551 Langsung | -24,45% | Dilepas | -71,8% (harga per 2026-08-21) |
| 10 Juli 2014 | PCRX | S 10b5-1 | 700 | $84,08 | $58.856 | 2.053 Langsung | -25,43% | Dilepas | -71,5% (harga per 2026-08-21) |
Menampilkan 100 dari 107 transaksi terakhir
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II)
Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 16 Juni 2026 | ENGNW | Stock Option (Right to Buy) | Common Shares (31.000) | $1,75 | 16 Juni 2036 | 31.000 | Diakuisisi |
| 6 Jan. 2026 | NKTX | Stock Option (right to buy) | Common Stock (562.000) | $1,93 | 5 Jan. 2036 | 562.000 | Diakuisisi |
| 16 Juni 2025 | ENGNW | Stock Option (Right to Buy) | Common Shares (22.500) | $3,31 | 16 Juni 2035 | 22.500 | Diakuisisi |
| 5 Juni 2025 | NKTX | Stock Option (right to buy) | Common Stock (377.000) | $1,83 | 5 Juni 2035 | 377.000 | Diakuisisi |
| 3 Jan. 2025 | NKTX | Stock Option (right to buy) | Common Stock (565.500) | $2,50 | 2 Jan. 2035 | 565.500 | Diakuisisi |
| 15 Juni 2024 | ENGNW | Stock Option (Right to Buy) | Common Shares (40.000) | $9,00 | 15 Juni 2034 | 40.000 | Diakuisisi |
| 12 Juni 2024 | PCRX | Stock Option (Right to Buy) | Common Stock (12.179) | $28,68 | 12 Juni 2034 | 12.179 | Diakuisisi |
| 4 Jan. 2024 | NKTX | Stock Option (right to buy) | Common Stock (509.500) | $6,01 | 3 Jan. 2034 | 509.500 | Diakuisisi |
| 14 Juni 2023 | PCRX | Stock Option (Right to Buy) | Common Stock (12.925) | $38,74 | 14 Juni 2033 | 12.925 | Diakuisisi |
| 15 Mei 2023 | PCRX | Stock Option (Right to Buy) | Common Stock (7.000) | $29,90 | 12 Juni 2023 | 7.000 | Dilepas |
| 13 Jan. 2023 | NKTX | Stock Option (right to buy) | Common Stock (386.500) | $5,57 | 12 Jan. 2033 | 386.500 | Diakuisisi |
| 17 Juni 2022 | NKTX | Stock Option (right to buy) | Common Stock (120.000) | $12,25 | 16 Juni 2032 | 120.000 | Diakuisisi |
| 8 Juni 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (8.225) | $59,39 | 8 Juni 2032 | 8.225 | Diakuisisi |
| 14 Jan. 2022 | NKTX | Stock Option (right to buy) | Common Stock (251.100) | $12,14 | 13 Jan. 2032 | 251.100 | Diakuisisi |
| 9 Juni 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (7.626) | $60,96 | 9 Juni 2031 | 7.626 | Diakuisisi |
| 5 Maret 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (3.000) | $13,98 | 2 Juni 2021 | 3.000 | Dilepas |
| 8 Jan. 2021 | NKTX | Stock Option (right to buy) | Common Stock (157.500) | $54,89 | 7 Jan. 2031 | 157.500 | Diakuisisi |
| 9 Juli 2020 | NKTX | Stock Option (right to buy) | Common Stock (202.400) | $18,00 | 8 Juli 2030 | 202.400 | Diakuisisi |
| 9 Juni 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (8.027) | $47,65 | 9 Juni 2030 | 8.027 | Diakuisisi |
| 5 Juni 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (8.437) | $43,54 | 5 Juni 2029 | 8.437 | Diakuisisi |
| 13 Juni 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (4.693) | $38,35 | 13 Juni 2028 | 4.693 | Diakuisisi |
| 8 Juni 2018 | TARA | Stock Option (Right to Buy) | Common Stock (12.700) | $2,50 | 7 Juni 2028 | 12.700 | Diakuisisi |
| 20 Juni 2017 | TARA | Stock Option (Right to Buy) | Common Stock, $0.001 par value (6.666) | $1,30 | 19 Juni 2027 | 6.666 | Diakuisisi |
| 14 Juni 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (2.714) | $44,20 | 14 Juni 2027 | 2.714 | Diakuisisi |
| 18 Okt. 2016 | TARA | Stock Option (Right to Buy) | Common Stock, $0.001 par value (13.333) | $9,00 | 17 Okt. 2026 | 13.333 | Diakuisisi |
| 15 Juni 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (2.975) | $40,34 | 15 Juni 2026 | 2.975 | Diakuisisi |
| 17 Feb. 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (1.000) | $10,81 | 4 Juni 2022 | 1.000 | Dilepas |
| 17 Feb. 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (2.000) | $13,98 | 2 Juni 2021 | 2.000 | Dilepas |
| 20 Nov. 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (3.000) | $10,81 | 4 Juni 2022 | 3.000 | Dilepas |
| 17 Agu 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (3.000) | $10,81 | 4 Juni 2022 | 3.000 | Dilepas |
| 3 Juni 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (4.000) | $79,43 | 3 Juni 2025 | 4.000 | Diakuisisi |
| 10 April 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (2.500) | $13,98 | 2 Juni 2021 | 2.500 | Dilepas |
| 12 Jan. 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (2.500) | $13,98 | 2 Juni 2021 | 2.500 | Dilepas |
| 10 Okt. 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (2.500) | $13,98 | 2 Juni 2021 | 2.500 | Dilepas |
| 10 Juli 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (2.500) | $13,98 | 2 Juni 2021 | 2.500 | Dilepas |
| 3 Juni 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (8.000) | $81,00 | 3 Juni 2024 | 8.000 | Diakuisisi |
| 12 Juni 2013 | PCRX | Stock Option (Right to Buy) | Common Stock (7.000) | $29,20 | 11 Juni 2023 | 7.000 | Diakuisisi |
| 5 Juni 2012 | PCRX | Common Stock | Common Stock (7.000) | $10,81 | 4 Juni 2022 | 7.000 | Diakuisisi |
| 2 Juni 2011 | PCRX | Stock option (right to buy) | Common Stock (15.000) | $13,98 | 2 Juni 2021 | 15.000 | Diakuisisi |
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kepemilikan Awal (Formulir 3) 5 saham
Sekuritas yang dipegang saat pertama kali menjadi orang dalam, sesuai Formulir 3 SEC.
| Tanggal | Ticker | Sekuritas | Saham | Kepemilikan |
|---|---|---|---|---|
| 9 Juli 2020 | NKTX | Common Stock | 253.061 | Langsung |
| 9 Juli 2020 | NKTX | Stock Option (right to buy)→ Common Stock | — | Langsung |
| 9 Juli 2020 | NKTX | Stock Option (right to buy)→ Common Stock | — | Langsung |
| 20 Okt. 2016 | TARA | Common Stock, $0.001 par value | 6.636 | Tidak Langsung |
| 6 Juni 2011 | PCRX | Common Stock | 0 | Langsung |
Kompensasi (DEF 14A)
Dicocokkan berdasarkan nama dari pernyataan proksi (DEF 14A) — verifikasi terhadap pengajuan.
NKTX
CEO| Tahun fiskal | Gaji | Bonus | Penghargaan saham | Penghargaan opsi | Insentif non-ekuitas | Perubahan Pensiun | Lainnya | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $674.384 | — | $236.250 | $1.711.957 | $344.947 | — | $10.500 | $2.978.038 |
| 2024 | $648.446 | — | $510.850 | $2.494.818 | $320.981 | — | $10.350 | $3.985.445 |
| 2022 | $599.525 | — | $747.541 | $3.058.795 | $329.739 | — | $9.150 | $4.744.750 |
Angka-angka dari Tabel Kompensasi Ringkasan dalam pernyataan proksi perusahaan (DEF 14A). Kompensasi bukan merupakan rekomendasi.